TargetMol

Triflusal

Product Code:
 
TAR-T0705
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T0705-5mg5mg£102.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T0705-1mL1 mL * 10 mM (in DMSO)£105.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T0705-10mg10mg£122.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T0705-25mg25mg£165.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T0705-50mg50mg£229.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T0705-100mg100mg£334.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T0705-200mg200mg£466.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T0705-500mg500mg£704.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Triflusal is a 2-acetoxy-4-trifluoromethylbenzoic acid and it is an aspirin chemically-related molecule but not a derivative.
CAS:
322-79-2
Formula:
C10H7F3O4
Molecular Weight:
248.157
Pathway:
Immunology/Inflammation; DNA Damage/DNA Repair; Metabolism; Neuroscience
Purity:
0.9315
SMILES:
CC(=O)Oc1cc(ccc1C(O)=O)C(F)(F)F
Target:
COX; PDE; PPAR

References

1. Duran X, et al. J Thromb Haemost, 2008, 6(8), 1385-1392. 2. Gonz?lez-Correa JA, et al. Naunyn Schmiedebergs Arch Pharmacol. 2005 Jan;371(1):81-8. 3. De Miguel LS, et al. Eur J Clin Invest, 2000, 30(9), 811-817. 4. Auteri A, et al. Int J Clin Pharmacol Res, 1995, 15(2), 57-63. 5. Acarin L, et al. Stroke, 2002, 33(10), 2499-2505.